ArticleEndocrine connections2025

Long-term efficacy of dapagliflozin combined with Bifidobacterium triple viable tablets on metabolic syndrome and gut microbiota in overweight/obese patients with type 2 diabetes.

Kunyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.